LMS increases the diagnosis and follow-up quality, which is good for the radiologists and of course patients, and the oncologists love the automatic report that is generated...
Press Releases
MEDIAN Technologies unveils new release of its Lesion Management Solutions focusing on helping the radiologists optimize their oncology related practices. LMS applications provide quantitative assessment of response to therapy with automatic generation of RECIST reports for oncology patients and computer aided detection and follow-up of indeterminate lung nodules. They are integrated with RIS/PACS for an optimized clinical workflow. MEDIAN will be presenting this new release at next European Congress of Radiology on booth #334, Hall C.
MEDIAN LMS-Lung and LMS-Liver empower the clinicians to increase standards of cancer patient care through the communication of comprehensive follow-up reports containing quantitative information about lesion growth and allowing a better assessment of response to therapy. Those reports can be done according to the RECIST criteria commonly used for clinical trials. Also included in LMS-Lung is a Computer Aided Detection function for a more reliable diagnosis of lung nodules.
“Cancer patient management today suffers from a lack of coordination between the medical specialties, and because oncology imaging reporting relies on qualitative instead of quantitative assessment of response to therapy,” explains Fredrik Brag, CEO of MEDIAN Technologies. “Our Lesion Management Solutions offer ways to standardize this reporting across cancer care networks for all patients thanks to their unique integration features.”
LMS applications can indeed be integrated with RIS/PACS, included in multi-site configurations, as it has been done recently in Brussels. Such integration optimizes the clinical workflow and communication between radiologists and oncologists and other referring physicians. For cancer patients, this means a more even and standardized management, with the additional benefit of a precise follow-up evaluation based on quantitative data.
About MEDIAN Technologies
MEDIAN Technologies develops and sells advanced clinical applications for oncology imaging. The company’s product line, MEDIAN LMS – Lesion Management Solutions – is a comprehensive portfolio of clinical applications for the management of cancerous or suspicious lesions diagnosed in CT scans. LMS applications feature LMS-Lung and LMS-Liver.